Key facts
- Virtonomy’s last known valuation is $21.5M.
- It has raised $18.5M; the latest was Later Stage VC ($5.8M) in Dec 2025.
- Notable investors include Plug and Play Tech Center, Bayern Kapital, Accenture Ventures, Companisto, Dieter von Holtzbrinck Ventures — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Virtonomy
- ·The full record, as it builds
Funding rounds
No funding rounds for Virtonomy are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Virtonomy
Developer of a digital twin and simulation system designed to streamline medical device development. The company's virtual trial platform supports the full product life cycle of development, from the concept phase to regulatory reporting and clinical practice, and helps cut down on development time, cost, and the potential risks associated with traditional clinical trials, enabling medical device developers to conduct testing and development within a safe, virtual environment.
- Sector
- Healthcare
- HQ
- Munich, Germany
- Founded
- 2019
- Employees
- 22
- Website
- virtonomy.io/
- Ownership
- Privately Held (backing)
Virtonomy doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Virtonomy shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Virtonomy in its N-PORT filings yet. We sweep new filings monthly.